Free Trial

Amrize Ltd (NYSE:AMRZ) Sees Significant Growth in Short Interest

Amrize logo with Basic Materials background

Key Points

  • Amrize Ltd experienced a dramatic increase in short interest, rising by 59.8% in September, totaling 8,740,000 shares as of September 30th.
  • The company's CFO, Ian A. Johnston, significantly increased his holdings by purchasing 10,500 shares at an average cost of $47.71, representing a 153.42% increase in ownership.
  • Analysts show mixed sentiments, with ratings ranging from "strong buy" to "hold," and a consensus price target set at $57.50.
  • Five stocks to consider instead of Amrize.

Amrize Ltd (NYSE:AMRZ - Get Free Report) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 8,740,000 shares, an increase of 59.8% from the September 15th total of 5,470,000 shares. Based on an average trading volume of 3,710,000 shares, the short-interest ratio is currently 2.4 days. Currently, 1.8% of the company's stock are sold short. Currently, 1.8% of the company's stock are sold short. Based on an average trading volume of 3,710,000 shares, the short-interest ratio is currently 2.4 days.

Insider Activity at Amrize

In related news, CFO Ian A. Johnston bought 10,500 shares of the stock in a transaction that occurred on Friday, August 8th. The stock was bought at an average cost of $47.71 per share, for a total transaction of $500,955.00. Following the purchase, the chief financial officer directly owned 17,344 shares of the company's stock, valued at approximately $827,482.24. This trade represents a 153.42% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jaime Hill bought 4,000 shares of the stock in a transaction that occurred on Friday, August 8th. The stock was bought at an average price of $46.40 per share, with a total value of $185,600.00. Following the completion of the purchase, the insider directly owned 9,601 shares in the company, valued at $445,486.40. This represents a 71.42% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 1,124,000 shares of company stock worth $53,225,260 over the last quarter.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. acquired a new position in shares of Amrize during the 2nd quarter valued at about $1,065,029,000. Norges Bank purchased a new stake in Amrize in the 2nd quarter valued at about $670,915,000. Dodge & Cox purchased a new stake in Amrize in the 2nd quarter valued at about $622,085,000. JPMorgan Chase & Co. purchased a new stake in Amrize in the 2nd quarter valued at about $220,404,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in Amrize by 247.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 4,386,926 shares of the company's stock valued at $212,449,000 after buying an additional 3,122,716 shares during the period.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on AMRZ shares. Barclays started coverage on shares of Amrize in a report on Tuesday, October 7th. They issued an "equal weight" rating for the company. Wells Fargo & Company raised shares of Amrize to a "strong-buy" rating in a report on Wednesday, October 8th. UBS Group boosted their price target on shares of Amrize from $49.00 to $52.00 and gave the stock a "neutral" rating in a report on Tuesday, October 14th. Zacks Research raised shares of Amrize from a "strong sell" rating to a "hold" rating in a report on Friday, October 10th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Amrize from $52.00 to $60.00 and gave the stock an "overweight" rating in a report on Tuesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Amrize has a consensus rating of "Moderate Buy" and a consensus price target of $57.50.

Get Our Latest Report on AMRZ

Amrize Trading Down 2.3%

Shares of AMRZ stock traded down $1.11 on Wednesday, hitting $47.93. 3,613,178 shares of the stock traded hands, compared to its average volume of 3,440,515. The company's 50-day moving average price is $50.60. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. Amrize has a twelve month low of $44.12 and a twelve month high of $56.29.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.03 by ($0.25). The firm had revenue of $3.22 billion for the quarter.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.